Farabi Pharmaceutical (XTEH:DFRB1) Interest Coverage: 0 (At Loss) (As of . 20)


What is Farabi Pharmaceutical Interest Coverage?

Farabi Pharmaceutical XTEH:DFRB1 Interest Coverage is 0 (At Loss) as of . 20.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Farabi Pharmaceutical's Operating Income for the three months ended in . 20 was IRR0.00 Mil. Farabi Pharmaceutical's Interest Expense for the three months ended in . 20 was IRR0.00 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

(1) Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Farabi Pharmaceutical's Interest Coverage or its related term are showing as below:


XTEH:DFRB1's Interest Coverage is not ranked *
in the Drug Manufacturers industry.
Industry Median: 12.75
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Farabi Pharmaceutical  (XTEH:DFRB1) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Farabi Pharmaceutical Interest Coverage Related Terms

Farabi Pharmaceutical Interest Coverage Historical Data

* Premium members only.

The historical data trend for Farabi Pharmaceutical's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Farabi Pharmaceutical Interest Coverage Chart

Farabi Pharmaceutical Annual Data
Trend
Interest Coverage

Farabi Pharmaceutical Quarterly Data
Interest Coverage

XTEH:DFRB1 vs IMNPQ, INNV: Interest Coverage Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Farabi Pharmaceutical's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Farabi Pharmaceutical Interest Coverage vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Farabi Pharmaceutical's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Farabi Pharmaceutical's Interest Coverage falls into.


Farabi Pharmaceutical Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Farabi Pharmaceutical's Interest Coverage for the fiscal year that ended in . 20 is calculated as

Here, for the fiscal year that ended in . 20, Farabi Pharmaceutical's Interest Expense was IRR0.00 Mil. Its Operating Income was IRR0.00 Mil. And its Long-Term Debt & Capital Lease Obligation was IRR0.00 Mil.

Farabi Pharmaceutical had no debt (1).

Farabi Pharmaceutical's Interest Coverage for the quarter that ended in . 20 is calculated as

Here, for the three months ended in . 20, Farabi Pharmaceutical's Interest Expense was IRR0.00 Mil. Its Operating Income was IRR0.00 Mil. And its Long-Term Debt & Capital Lease Obligation was IRR0.00 Mil.

Farabi Pharmaceutical had no debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Frequently Asked Questions Learn more about Interest Coverage →
What does a Interest Coverage of 0 (At Loss) mean?
Farabi Pharmaceutical (XTEH:DFRB1) has a Interest Coverage of 0 (At Loss) as of . 20. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Farabi Pharmaceutical and its competitors.
Is Farabi Pharmaceutical's Interest Coverage too high?
Farabi Pharmaceutical's current Interest Coverage is 0 (At Loss).
How does Farabi Pharmaceutical's Interest Coverage compare to IMNPQ and INNV?
Farabi Pharmaceutical's Interest Coverage of 0 (At Loss) can be compared against companies in the Drug Manufacturers industry. The industry median Interest Coverage is 12.75. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.75, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Farabi Pharmaceutical and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Farabi Pharmaceutical's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farabi Pharmaceutical stock overvalued right now?
Farabi Pharmaceutical (XTEH:DFRB1) has a current Interest Coverage of 0 (At Loss). The current Interest Coverage is 0 (At Loss). Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Farabi Pharmaceutical (XTEH:DFRB1), the current Interest Coverage is 0 (At Loss) as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Farabi Pharmaceutical Business Description

Address South Kheradmand, No. 45, First Floor, Tehran, IRN, 1584853114
Farabi Pharmaceutical is a pharmaceutical company based in Iran. It produces various oral antibiotic-related and non-antibiotic products and dietary supplements. The company develops anti-migraine, antivirals, cholesterol, diabetic, cardiovascular, gastrointestinal, neuroleptics, anti-prostatic and anti-inflammatory and pain release drugs. It offers products in the form of tablet, capsule and suspensions which include Amoxicillin, Cefixime, Azithromycin, Ciprofloxacin, Nitroglycerin, Repaglinide, Orlistat, Domperidone, among others.